Enzon Pharmaceuticals Inc (OTCQX US:ENZN)

0.261
Delayed Data
As of Apr 20
 -0.00004 / -0.02%
Today’s Change
0.03
Today|||52-Week Range
0.35
-3.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line28.8M21.6M-1.1M5.4M
 
 
 
 
 
Total Other Cash Flow-61.0K0.000.000.00
 
 
Funds From Operations28.7M10.5M6.6M8.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-3.6M-4.2M4.0M2.3M
 
 
 
 
 
Net Cash Flow - Operating Activities32.3M14.7M2.6M6.5M
 
 
 
 
 
 
InvestingFixed Asset Disposal151.0K0.000.000.00
 
 
Net Cash Flow Investing151.0K0.000.000.00
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed0.000.000.000.00--
Common Dividends-4.4M-37.6M-6.6M-6.6M
 
 
 
 
 
Cash Dividends Paid - Total-4.4M-37.6M-6.6M-6.6M
 
 
 
 
 
Other Sources - Financing----0.000.00--
Other Uses - Financing30.0K6.0K0.000.00
 
 
 
Net Cash Flow - Financing-4.4M-37.6M-6.6M-6.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash28.0M-22.9M-4.0M-161.0K